Table 3.

Rates of the Primary and Secondary Clinical Endpoints Between Groups

Outcome	In-Hospital Bleeding (n = 14,107)	No In-Hospital Bleeding (n = 447,204)	p Value
Readmission for bleeding
1 month	0.9 (0.7–1.0)	0.3 (0.3–0.4)	<0.001
12 months	3.9 (3.5–4.3)	1.9 (1.9–2.0)	<0.001
30 months	5.9 (5.2–6.6)	3.4 (3.3–3.5)	<0.001
MACE*
1 month	6.7 (6.2–7.2)	5.7 (5.6–5.8)	<0.001
12 months	30.6 (29.5–31.7)	24.1 (23.9–24.3)	<0.001
30 months	51.4 (49.4–53.3)	43.5 (43.2–43.9)	<0.001
All-cause mortality
1 month	2.3 (2.1–2.6)	1.0 (1.0–1.1)	<0.001
12 months	13.7 (13.1–14.3)	6.9 (6.8–6.9)	<0.001
30 months	24.1 (23.2–25.0)	14.2 (14.1–14.3)	<0.001

Values are % (95% confidence intervals).

^*Death, MI, revascularization.

MACE = major adverse cardiac events; MI = myocardial infarction.